SOPHiA GENETICS SA
SOPH
134 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Oct 14 8:04 PM | Philippe MenuChief Medical Officer | Sale | 5,000 | $7.26 | $36.3K | 195,993(D) | View → |
| Oct 13, 2026 | Oct 14 8:03 PM | Zhenyu XuChief Scientific Officer | Sale | 4,000 | $7.18 | $28.7K | 541,493(D) | View → |
| Oct 12, 2026 | Oct 14 8:02 PM | Jurgi CamblongDirector, Executive Chairman | Sale | 8,500 | $7.26 | $61.7K | 3,387,150(D) | View → |
| Oct 5, 2026 | Oct 7 8:04 PM | Well Daan VanChief Legal Officer | Sale | 6,168 | $8.12 | $50.1K | 332,716(D) | View → |
| Oct 5, 2026 | Oct 7 8:04 PM | Manuela ValenteChief People Officer | Sale | 4,240 | $8.13 | $34.5K | 206,210(D) | View → |
| Oct 5, 2026 | Oct 7 8:04 PM | Abhimanyu VermaChief Technology Officer | Sale | 5,284 | $8.12 | $42.9K | 166,887(D) | View → |
| Oct 5, 2026 | Oct 7 8:04 PM | Kevin PuylaertChief Sales Officer | Sale | 216 | $8.04 | $1.7K | 147,732(D) | View → |
| Oct 5, 2026 | Oct 7 8:04 PM | George CardozaChief Financial Officer | Sale | 1,592 | $8.10 | $12.9K | 306,726(D) | View → |
| Oct 5, 2026 | Oct 7 8:04 PM | Philippe MenuChief Medical Officer | Sale | 7,394 | $8.13 | $60.1K | 200,993(D) | View → |
| Oct 5, 2026 | Oct 7 8:04 PM | Jurgi CamblongDirector, Executive Chairman | Sale | 40,172 | $8.13 | $326.5K | 3,395,650(D) | View → |
| Oct 5, 2026 | Oct 7 8:04 PM | Zhenyu XuChief Scientific Officer | Sale | 7,394 | $8.12 | $60.1K | 545,493(D) | View → |
| Oct 5, 2026 | Oct 7 8:03 PM | Ross MukenDirector, Chief Executive Officer | Sale | 9,838 | $8.13 | $80.0K | 660,391(D) | View → |
| Oct 5, 2026 | Oct 5 8:45 PM | ZHENYU XU | Proposed Sale | 19,394 | $8.07 | $156.5K | — | View → |
| Oct 5, 2026 | Oct 5 8:45 PM | DAAN GUIDO MARIA VAN WELL | Proposed Sale | 6,168 | $8.07 | $49.8K | — | View → |
| Oct 5, 2026 | Oct 5 8:43 PM | ROSS J MUKEN | Proposed Sale | 9,838 | $8.07 | $79.4K | — | View → |
| Oct 5, 2026 | Oct 5 8:43 PM | PHILIPPE MENU | Proposed Sale | 22,394 | $8.07 | $180.7K | — | View → |
| Oct 5, 2026 | Oct 5 8:43 PM | MANUELA VALENTE | Proposed Sale | 4,240 | $8.07 | $34.2K | — | View → |
| Oct 5, 2026 | Oct 5 8:42 PM | GEORGE CARDOZA | Proposed Sale | 1,592 | $8.07 | $12.8K | — | View → |
| Oct 5, 2026 | Oct 5 8:41 PM | JURGI CAMBLONG | Proposed Sale | 65,672 | $8.07 | $530.0K | — | View → |
| Sep 21, 2026 | Sep 22 8:02 PM | George CardozaChief Financial Officer | Sale | 774 | $8.33 | $6.4K | 308,318(D) | View → |
Page 1 of 15
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Apr 8 12:46 PM | Abhimanyu VermaChief Technology Officer | Grant/Award | 119,760 | $5.04 | 119,760(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Abhimanyu VermaChief Technology Officer | Grant/Award | 119,760 | $5.04 | 119,760(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Ross MukenPresident | Grant/Award | 628,743 | $5.04 | 628,743(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Philippe MenuChief Medical Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Zhenyu XuChief Scientific Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Jurgi CamblongDirector, Chief Executive Officer | Grant/Award | 628,743 | $5.04 | 628,743(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Kevin PuylaertChief Sales Officer | Grant/Award | 82,335 | $5.04 | 82,335(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | George CardozaChief Financial Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Manuela ValenteChief People Officer | Grant/Award | 104,790 | $5.04 | 104,790(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Well Daan VanChief Legal Officer | Grant/Award | 142,216 | $5.04 | 142,216(D) | View → |
← Previous
Page 2 of 2